Recombinant SARS-CoV-2 Vaccine(Shanghai Zerun )
重组新型冠状病毒疫苗（上海泽润）
Report date: 2022/07/04 19:38:02
Base Information
Drug NameRecombinant SARS-CoV-2 Vaccine(Shanghai Zerun )
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Zerun Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesWalvax Biotechnology Co LtdShanghai Zerun Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A